Benjamin Pariente

8.1k total citations
88 papers, 1.8k citations indexed

About

Benjamin Pariente is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Benjamin Pariente has authored 88 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 75 papers in Genetics, 58 papers in Epidemiology and 37 papers in Surgery. Recurrent topics in Benjamin Pariente's work include Inflammatory Bowel Disease (75 papers), Microscopic Colitis (51 papers) and Eosinophilic Esophagitis (16 papers). Benjamin Pariente is often cited by papers focused on Inflammatory Bowel Disease (75 papers), Microscopic Colitis (51 papers) and Eosinophilic Esophagitis (16 papers). Benjamin Pariente collaborates with scholars based in France, United States and Belgium. Benjamin Pariente's co-authors include Matthieu Allez, David Laharie, Laurent Peyrin‐Biroulet, Jean‐Marc Gornet, Silvio Danese, Clotilde Baudry, Gionata Fiorino, Pierre Desreumaux, Guillaume Pineton de Chambrun and Nelson Lourenço and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and American Journal Of Pathology.

In The Last Decade

Benjamin Pariente

83 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Benjamin Pariente France	23	1.4k	1.1k	665	420	155	88	1.8k
Judith Collins United States	9	1.3k 0.9×	1.0k 1.0×	354 0.5×	357 0.8×	178 1.1×	18	1.7k
Triana Lobatón Belgium	23	1.3k 0.9×	1.1k 1.0×	601 0.9×	298 0.7×	217 1.4×	98	1.8k
A. Cassinotti Italy	24	1.2k 0.8×	987 0.9×	497 0.7×	394 0.9×	246 1.6×	59	2.0k
Gilles Boschetti France	25	1.1k 0.8×	944 0.9×	778 1.2×	538 1.3×	135 0.9×	89	2.0k
Sara Onali Italy	26	1.1k 0.7×	709 0.7×	514 0.8×	269 0.6×	190 1.2×	68	1.5k
Edyta Zagórowicz Poland	11	1.2k 0.8×	959 0.9×	539 0.8×	182 0.4×	217 1.4×	29	1.6k
Julien Branche France	18	1.1k 0.8×	857 0.8×	805 1.2×	295 0.7×	91 0.6×	46	1.8k
Jeroen M. Jansen Netherlands	19	1.2k 0.9×	944 0.9×	362 0.5×	442 1.1×	85 0.5×	48	1.5k
Klaudia Farkas Hungary	21	784 0.5×	594 0.6×	507 0.8×	382 0.9×	178 1.1×	155	1.5k
Rodolfo Rocca Italy	16	1.6k 1.1×	1.3k 1.2×	963 1.4×	297 0.7×	288 1.9×	53	2.1k

Countries citing papers authored by Benjamin Pariente

Since Specialization

Citations

This map shows the geographic impact of Benjamin Pariente's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Pariente with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Pariente more than expected).

Fields of papers citing papers by Benjamin Pariente

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benjamin Pariente. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Pariente. The network helps show where Benjamin Pariente may publish in the future.

Co-authorship network of co-authors of Benjamin Pariente

This figure shows the co-authorship network connecting the top 25 collaborators of Benjamin Pariente. A scholar is included among the top collaborators of Benjamin Pariente based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benjamin Pariente. Benjamin Pariente is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Vieujean, Sophie, Benjamin Pariente, Alexandra Briquet, et al.. (2021). P293 Local Mesenchymal Stem Cells injection in Crohn’s disease strictures: a phase I-II, open-label clinical study. Journal of Crohn s and Colitis. 15(Supplement_1). S323–S324. 5 indexed citations

Laharie, David, Stéphane Nancey, Xavier Hébuterne, et al.. (2020). Variation of faecal calprotectin level within the first three months after bowel resection is predictive of endoscopic postoperative recurrence in Crohn's disease. Digestive and Liver Disease. 52(7). 740–744. 10 indexed citations

Dreesen, Erwin, Filip Baert, David Laharie, et al.. (2019). Monitoring a Combination of Calprotectin and Infliximab Identifies Patients With Mucosal Healing of Crohn’s Disease. Clinical Gastroenterology and Hepatology. 18(3). 637–646.e11. 60 indexed citations

Brand, Eelco C., Sjoerd G. Elias, Itta M. Minderhoud, et al.. (2019). Systematic Review and External Validation of Prediction Models Based on Symptoms and Biomarkers for Identifying Endoscopic Activity in Crohn's Disease. Clinical Gastroenterology and Hepatology. 18(8). 1704–1718. 19 indexed citations

Engel, Tal, Diana E. Yung, Christopher Ma, et al.. (2019). Effectiveness and safety of Ustekinumab for Crohn's disease; systematic review and pooled analysis of real-world evidence. Digestive and Liver Disease. 51(9). 1232–1240. 49 indexed citations

Auzolle, Claire, Stéphane Nancey, My‐Linh Tran‐Minh, et al.. (2018). Male gender, active smoking and previous intestinal resection are risk factors for post‐operative endoscopic recurrence in Crohn's disease: results from a prospective cohort study. Alimentary Pharmacology & Therapeutics. 48(9). 924–932. 63 indexed citations

Gagnière, Charlotte, Anne Bourrier, Philippe Seksik, et al.. (2018). Risk of serious infection in healthcare workers with inflammatory bowel disease: a case‐control study of the Groupe d'Etude Thérapeutique des Affections Inflammatoires du tube Digestif (GETAID). Alimentary Pharmacology & Therapeutics. 48(7). 713–722. 7 indexed citations

Pouillon, Lieven, Guillaume Pineton de Chambrun, Lucine Vuitton, et al.. (2018). Dose de-escalation to adalimumab 40 mg every three weeks in patients with inflammatory bowel disease—A multicenter, retrospective, observational study. Digestive and Liver Disease. 51(2). 236–241. 12 indexed citations

Sacleux, Sophie‐Caroline, Hélène Sarter, Mathurin Fumery, et al.. (2018). Post‐operative complications in elderly onset inflammatory bowel disease: a population‐based study. Alimentary Pharmacology & Therapeutics. 47(12). 1652–1660. 11 indexed citations

10.

Ghione, S, Hélène Sarter, Mathurin Fumery, et al.. (2017). Dramatic Increase in Incidence of Ulcerative Colitis and Crohn's Disease (1988–2011): A Population-Based Study of French Adolescents. The American Journal of Gastroenterology. 113(2). 265–272. 109 indexed citations

11.

Nachury, Maria, Romain Gérard, Julien Branche, et al.. (2016). Adalimumab dose escalation is effective and well tolerated in Crohn’s disease patients with secondary loss of response to adalimumab. Digestive and Liver Disease. 49(2). 163–169. 13 indexed citations

12.

Dauchet, Luc, Mathurin Fuméry, Cloé Charpentier, et al.. (2016). Cancer in Elderly Onset Inflammatory Bowel Disease: A Population-Based Study. The American Journal of Gastroenterology. 111(10). 1428–1436. 54 indexed citations

13.

Nachury, Maria, Philippe Zerbib, Romain Gérard, et al.. (2016). Ileal or Anastomotic Location of Lesions Does Not Impact Rate of Postoperative Recurrence in Crohn’s Disease Patients Classified i2 on the Rutgeerts Score. Digestive Diseases and Sciences. 61(10). 2986–2992. 29 indexed citations

14.

Simon, M., Jacques Cosnes, J.M. Gornet, et al.. (2016). Endoscopic Detection of Small Bowel Dysplasia and Adenocarcinoma in Crohn’s Disease: A Prospective Cohort-Study in High-Risk Patients. Journal of Crohn s and Colitis. 11(1). 47–52. 19 indexed citations

15.

Gilletta, Cyrielle, M. Lewin, Anne Bourrier, et al.. (2015). Changes in the Lémann Index Values During the First Years of Crohn’s Disease. Clinical Gastroenterology and Hepatology. 13(9). 1633–1640.e3. 38 indexed citations

16.

Pariente, Benjamin & David Laharie. (2014). Review article: why, when and how to de‐escalate therapy in inflammatory bowel diseases. Alimentary Pharmacology & Therapeutics. 40(4). 338–353. 61 indexed citations

17.

Munoz‐Bongrand, Nicolas, Benjamin Pariente, Clotilde Baudry, et al.. (2014). Endoscopic and Clinical Recurrences After Laparoscopic or Open Ileocolic Resection in Crohn's Disease. Journal of Laparoendoscopic & Advanced Surgical Techniques. 24(9). 617–622. 7 indexed citations

18.

Chirica, Mircéa, Matthieu Resche‐Rigon, Benjamin Pariente, et al.. (2014). Computed tomography evaluation of high-grade esophageal necrosis after corrosive ingestion to avoid unnecessary esophagectomy. Surgical Endoscopy. 29(6). 1452–1461. 38 indexed citations

19.

Gagnière, Charlotte, Laurent Beaugerie, Benjamin Pariente, et al.. (2014). Benefit of Infliximab Reintroduction after Successive Failure of Infliximab and Adalimumab in Crohn's Disease. Journal of Crohn s and Colitis. 9(4). 349–355. 15 indexed citations

20.

Esses, Steven J., Benjamin Pariente, Lionel Le Bourhis, et al.. (2013). Oligoclonal expansions of mucosal T cells in Crohn's disease predominate in NKG2D-expressing CD4 T cells. Mucosal Immunology. 7(2). 325–334. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact